Page last updated: 2024-08-21

maleamic acid and Bone Loss, Osteoclastic

maleamic acid has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furuta, Y; Higaki, K; Izumi, T; Kasuya, Y; Kurihara, A; Miyaji, Y; Ogawara, K; Okazaki, O; Takahashi, M	1

Other Studies

1 other study(ies) available for maleamic acid and Bone Loss, Osteoclastic

Article	Year
Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. Pharmaceutical research, 2012, Volume: 29, Issue:11 Topics: Administration, Intravenous; Animals; Bone and Bones; Bone Marrow; Bone Resorption; Drug Carriers; Drug Delivery Systems; Female; Humans; Maleates; Osteoclasts; Osteoprotegerin; Ovariectomy; Polyethylene Glycols; Polymers; Rats; Rats, Inbred F344; Recombinant Proteins; Structure-Activity Relationship; Tissue Distribution	2012

Article

Year

Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats.

Pharmaceutical research, 2012, Volume: 29, Issue:11

Topics: Administration, Intravenous; Animals; Bone and Bones; Bone Marrow; Bone Resorption; Drug Carriers; Drug Delivery Systems; Female; Humans; Maleates; Osteoclasts; Osteoprotegerin; Ovariectomy; Polyethylene Glycols; Polymers; Rats; Rats, Inbred F344; Recombinant Proteins; Structure-Activity Relationship; Tissue Distribution

2012